Sanofi Presses Fed. Circ. To Nix Dr. Reddy's Allegra Win

Law360, New York (December 5, 2011, 2:32 PM EST) -- Sanofi Aventis US LLC asked the Federal Circuit on Monday to overturn a win for generics maker Dr. Reddy's Laboratories Inc. in an infringement suit over allergy drug Allegra, arguing the lower court misinterpreted a key term.

In January, a New Jersey federal judge threw out a June 2010 preliminary injunction granted in Sanofi's infringement suit against the generics maker that had barred Dr. Reddy's from selling 24-hour fexofenadine hydrochloride/pseudoephedrine hydrochloride extended-release tablets in the U.S.

The judge ruled that Sanofi and fellow plaintiff Albany Molecular...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.